Found: 111
Select item for more details and to access through your institution.
Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile.
- Published in:
- Obesity (19307381), 2024, v. 32, n. 7, p. 1235, doi. 10.1002/oby.24019
- By:
- Publication type:
- Article
Pyrrole‐Thiazolidin‐4‐one Analogues Exhibit Promising Anti‐Tuberculosis Activity.
- Published in:
- Asian Journal of Organic Chemistry, 2024, v. 13, n. 6, p. 1, doi. 10.1002/ajoc.202400054
- By:
- Publication type:
- Article
Interfering with reconsolidation by rimonabant results in blockade of heroin-associated memory.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1361838
- By:
- Publication type:
- Article
One‐Pot Double Oxidation Synthesis of N‐1‐Piperidonyl Amides From N‐1‐Piperidinyl Amides with meta‐Chloroperbenzoic Acid: Rimonabant Analogue as Model Study.
- Published in:
- Chemistry - A European Journal, 2023, v. 29, n. 45, p. 1, doi. 10.1002/chem.202300702
- By:
- Publication type:
- Article
Co-administration of rimonabant prevents glucose intolerance in Sprague-Dawley rats treated chronically with lopinavir/ritonavir and zidovudine: an experimental study design.
- Published in:
- Pan African Medical Journal, 2023, v. 45, p. 1, doi. 10.11604/pamj.2023.45.6.21541
- By:
- Publication type:
- Article
Tethered agonist activated ADGRF1 structure and signalling analysis reveal basis for G protein coupling.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38083-7
- By:
- Publication type:
- Article
Context-dependent effects of the CB1 receptor antagonist rimonabant on morphine-induced behavioral sensitization in female mice.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1100527
- By:
- Publication type:
- Article
Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 20, p. 3262, doi. 10.3390/cells11203262
- By:
- Publication type:
- Article
Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 7886, doi. 10.3390/ijms23147886
- By:
- Publication type:
- Article
Comparative effects of cannabinoid CB1 receptor agonist and antagonist on timing impulsivity induced by d-amphetamine in a differential reinforcement of low-rate response task in male rats.
- Published in:
- Psychopharmacology, 2022, v. 239, n. 5, p. 1459, doi. 10.1007/s00213-021-06018-z
- By:
- Publication type:
- Article
CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Possible Role of Adipose Tissue and the Endocannabinoid System in Coronavirus Disease 2019 Pathogenesis: Can Rimonabant Return?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rimonabant suppresses RNA transcription of hepatitis B virus by inhibiting hepatocyte nuclear factor 4α.
- Published in:
- Microbiology & Immunology, 2020, v. 64, n. 5, p. 345, doi. 10.1111/1348-0421.12777
- By:
- Publication type:
- Article
CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A).
- Published in:
- Molecules, 2020, v. 25, n. 4, p. 896, doi. 10.3390/molecules25040896
- By:
- Publication type:
- Article
Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2019, v. 28, n. 4, p. 473, doi. 10.15403/jgld-265
- By:
- Publication type:
- Article
Bone Anabolic Response in the Calvaria Following Mild Traumatic Brain Injury is Mediated by the Cannabinoid-1 Receptor.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-51720-w
- By:
- Publication type:
- Article
Analysis of Direct Effects of the CB1 Receptor Antagonist Rimonabant on Fatty Acid Oxidation and Glycogenolysis in Liver and Muscle Cells in vitro.
- Published in:
- Biochemistry (00062979), 2019, v. 84, n. 8, p. 954, doi. 10.1134/S000629791908011X
- By:
- Publication type:
- Article
Cannabinoid CB<sub>1</sub> Receptor Antagonist Rimonabant Decreases Levels of Markers of Organ Dysfunction and Alters Vascular Reactivity in Aortic Vessels in Late Sepsis in Rats.
- Published in:
- Inflammation, 2019, v. 42, n. 2, p. 618, doi. 10.1007/s10753-018-0919-z
- By:
- Publication type:
- Article
Synthesis and Anticancer Activity of 1,2,3-Triazole Fused N-Arylpyrazole Derivatives.
- Published in:
- Russian Journal of General Chemistry, 2019, v. 89, n. 4, p. 831, doi. 10.1134/S1070363219040315
- By:
- Publication type:
- Article
The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00207
- By:
- Publication type:
- Article
The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder.
- Published in:
- Frontiers in Psychiatry, 2019, p. N.PAG, doi. 10.3389/fpsyt.2019.00063
- By:
- Publication type:
- Article
Novel Fubinaca/Rimonabant hybrids as endocannabinoid system modulators.
- Published in:
- Amino Acids, 2018, v. 50, n. 11, p. 1595, doi. 10.1007/s00726-018-2636-1
- By:
- Publication type:
- Article
CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0206152
- By:
- Publication type:
- Article
Cannabinoid receptor-1 signaling contributions to sign-tracking and conditioned reinforcement in rats.
- Published in:
- Psychopharmacology, 2018, v. 235, n. 10, p. 3031, doi. 10.1007/s00213-018-4993-6
- By:
- Publication type:
- Article
Computational investigation on the binding modes of Rimonabant analogs with CB1 and CB2.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1699, doi. 10.1111/cbdd.13337
- By:
- Publication type:
- Article
Δ<sup>9 </sup>-Tetrahydrocannabinol-like discriminative stimulus effects of five novel synthetic cannabinoids in rats.
- Published in:
- Psychopharmacology, 2018, v. 235, n. 3, p. 673, doi. 10.1007/s00213-017-4783-6
- By:
- Publication type:
- Article
Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2017.00949
- By:
- Publication type:
- Article
A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats.
- Published in:
- Acta Neuropsychiatrica, 2017, v. 29, n. 6, p. 324, doi. 10.1017/neu.2016.68
- By:
- Publication type:
- Article
Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 42, n. 6, p. 2281, doi. 10.1159/000480001
- By:
- Publication type:
- Article
Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain.
- Published in:
- Journal of Neuroscience, 2017, v. 37, n. 3, p. 626, doi. 10.1523/JNEUROSCI.1310-16.2017
- By:
- Publication type:
- Article
The CB<sub>1</sub> Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
- Published in:
- International Journal of Neuropsychopharmacology, 2016, v. 19, n. 12, p. 1, doi. 10.1093/ijnp/pyw068
- By:
- Publication type:
- Article
Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model.
- Published in:
- Genes, 2016, v. 7, n. 9, p. 56, doi. 10.3390/genes7090056
- By:
- Publication type:
- Article
The CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers.
- Published in:
- International Journal of Neuropsychopharmacology, 2016, v. 19, n. 2, p. 1, doi. 10.1093/ijnp/pyv092
- By:
- Publication type:
- Article
Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait.
- Published in:
- Neural Plasticity, 2015, v. 2015, p. 1, doi. 10.1155/2016/6481862
- By:
- Publication type:
- Article
Mitochondrial ADP/ATP exchange inhibition: a novel off-target mechanism underlying ibipinabant-induced myotoxicity.
- Published in:
- Scientific Reports, 2015, p. 14533, doi. 10.1038/srep14533
- By:
- Publication type:
- Article
Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.
- Published in:
- Psychopharmacology, 2015, v. 232, n. 15, p. 2751, doi. 10.1007/s00213-015-3907-0
- By:
- Publication type:
- Article
Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin on Food Reward and Aversion in Healthy Volunteers.
- Published in:
- International Journal of Neuropsychopharmacology, 2015, v. 18, n. 6, p. 1, doi. 10.1093/ijnp/pyu094
- By:
- Publication type:
- Article
Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2014, v. 92, n. 12, p. 975, doi. 10.1139/cjpp-2014-0310
- By:
- Publication type:
- Article
Rimonabant's reductive effects on high densities of food reinforcement, but not palatability, in lean and obese Zucker rats.
- Published in:
- Psychopharmacology, 2014, v. 231, n. 10, p. 2159, doi. 10.1007/s00213-013-3366-4
- By:
- Publication type:
- Article
Differentiation between low- and high-efficacy CB receptor agonists using a drug discrimination protocol for rats.
- Published in:
- Psychopharmacology, 2014, v. 231, n. 3, p. 489, doi. 10.1007/s00213-013-3257-8
- By:
- Publication type:
- Article
The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 1, p. 21, doi. 10.1111/bcp.12102
- By:
- Publication type:
- Article
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 1, p. 94, doi. 10.1002/hup.2374
- By:
- Publication type:
- Article
Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 6, p. 846, doi. 10.1111/bcp.12141
- By:
- Publication type:
- Article
Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.
- Published in:
- Endocrine (1355008X), 2013, v. 44, n. 3, p. 583, doi. 10.1007/s12020-013-9971-5
- By:
- Publication type:
- Article
Rimonabant Precipitates Anxiety in Rats Withdrawn from Palatable Food: Role of the Central Amygdala.
- Published in:
- Neuropsychopharmacology, 2013, v. 38, n. 12, p. 2498, doi. 10.1038/npp.2013.153
- By:
- Publication type:
- Article
The Gastric CB1 Receptor Modulates Ghrelin Production through the mTOR Pathway to Regulate Food Intake.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0080339
- By:
- Publication type:
- Article
Reduced Food Intake is the Major Contributor to the Protective Effect of Rimonabant on Islet in Established Obesity-Associated Type 2 Diabetes.
- Published in:
- Yonsei Medical Journal, 2013, v. 54, n. 5, p. 1127, doi. 10.3349/ymj.2013.54.5.1127
- By:
- Publication type:
- Article
Rehabilitating rimonabant.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity.
- Published in:
- International Journal of Obesity, 2013, v. 37, n. 6, p. 874, doi. 10.1038/ijo.2012.123
- By:
- Publication type:
- Article
CB<sub>1</sub> blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans.
- Published in:
- International Journal of Obesity, 2013, v. 37, n. 5, p. 699, doi. 10.1038/ijo.2012.116
- By:
- Publication type:
- Article